Raùl Torres Ruiz

Raul Torres-Ruiz's research career has focused on genome engineering tools development broadly applicable to studying and treating human genetic diseases. Delivery of gene editing tools is perhaps one of the main barriers to the widespread use of genome editing technologies. He has been involved in several research projects to engineer viral delivery systems that can be combined with genetic editing nucleases such as CRISPR/Cas9. In the last years, he has focused his efforts in the development of new therapeutic approaches -based on gene editing and gene therapy- for the treatment of rare cancers and monogenic clotting disorders.